Stocktoria

Neuraxis, INC NRXS

NYSE · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 2023-08-09

Neuraxis, INC statistics & valuation

Market cap$88.4M
P / S24.8×
P / B26.0×
Net margin-218.5%
FCF margin-181.1%
Return on capital-216.8%

Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-178.00% -594.60% -306.80% -218.50% 2022202320242025
Gross margin (%)
88.90% 87.70% 86.50% 84.20% 2022202320242025
Operating margin (%)
-125.60% -270.90% -266.50% -219.40% 2022202320242025
Return on equity (%)
-398.60% -229.50% 2022202320242025
Shares outstanding
2.0M 6.5M 7.0M 10.7M 2022202320242025
Net debt ($)
-$25357 2022202320242025
Share buybacks ($)
2022202320242025
Return on assets (%)
-322.80% -2870.80% -173.20% -121.80% 2022202320242025
Free cash flow margin (%)
-85.60% -273.40% -228.10% -181.10% 2022202320242025
Debt / equity (×)
2022202320242025
EPS ($)
-$2.77 -$4.50 -$1.22 -$0.95 2022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022
Gross margin84.2%86.5%87.7%88.9%
Operating margin-219.4%-266.5%-270.9%-125.6%
Net margin-218.5%-306.8%-594.6%-178.0%
FCF margin-181.1%-228.1%-273.4%-85.6%
Return on assets-121.8%-173.2%-2870.8%-322.8%
Return on equity-229.5%-398.6%1042.4%85.8%
Debt / equity———-0.04×
Current ratio2.051.750.130.07

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.